SARASOTA, Fla., April 20, 2018 -- via OTC PR WIRE--International Consolidated Companies, Inc. (OTC:INCC), is happy to report it’s subsidiary BluDog Products LLC has formed a strategic partnership with, Colorado based, Natures Renewable LLC to be its exclusive CBD supplier.
“This gives us the third leg to the stool, we have the BluDog brand, we are vertically integrating our manufacturing and we have supply of CBD to make great products that we feel will change people’s lives!” said Antonio Uccello, Managing Member of BluDog Products LLC.
Nature’s Renewable will be the exclusive supplier of CBD isolate and full spectrum oil to BluDog Products. Nature’s Renewable is committed to initially providing BluDog Products up to 1,000 kilos per month. The retail value of CBD is anywhere from $6,000 to $10,000 per kilo.
“We are excited to provide BluDog Products with the highest quality MEDICAL GRADE CBD.” said Tom Ward, Managing Member of Nature’s Renewable LLC.
International Consolidated Companies (INCC) was founded in 2002. INCC is focused on acquiring and growing businesses that offer innovation, quality, and cost-efficient Cannabis technologies.
Forward-looking disclaimer
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material may contain statements about expected future events and/or financial results that are forward-looking in nature and subject to risk and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements to be materially different from the statements made herein.
More Information: Antonio F. Uccello, INCC; (720-460-0734) ([email protected]), www.BluDogProducts.com , @BluDogProducts
SOURCE: International Consolidated Companies, Inc.


SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
Tesla Raises Cybertruck Prices by $5,000 in US
OpenAI AI Agent Swarm Behind Hugging Face Hack
Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover
Bathla Group Hires Administrators as Australia Housing Slump Deepens
Trump Buys SpaceX Shares After Record IPO
Google Expands Gemini Enterprise With AI Tools for Legal Sector
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules
Mercer International Stock Surges 45% on C$20 Million Canada Funding
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation
Luxshare Shares Rise as First-Half Profit Jumps 18%
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 



